Skip to main content
. 2015 Aug 4;9:1–10. doi: 10.1016/j.ijcha.2015.07.010

Table 1.

Clinical and echocardiographic characteristics of the patients in this study (n = 123).

Variable Group 1
Mean LV thickness < 12 mm
(n = 47)
Group 2
CHF(−) and BNP < 100 pg/mL
(n = 35)
Group 3
CHF(+) or BNP ≥ 100 pg/mL
(n = 41)
Age, year 44 ± 13 62 ± 12* 63 ± 12*
Gender (male/female), n 22/25 26/9 19/22
Type of mutation
V30M/non-V30M
47/0 34/1 (S50R) 33/8 [D38A (3), S50I (1), E54K (1), E42G(1), S50R (1), H88R (1)]
Systolic blood pressure, mm Hg 112 ± 10 120 ± 19 107 ± 17§
Diastolic blood pressure, mm Hg 71 ± 10 78 ± 13# 65 ± 12#,
Heart rate, bpm 70 ± 13 61 ± 11 61 ± 11
Left atrial diameter, cm 3.33 ± 0.47 4.09 ± 0.67 4.24 ± 0.70
Left atrial volume max, mL 48 ± 18 68 ± 28 81 ± 28,⁎⁎
Left atrial volume min, mL 21 ± 10 34 ± 20# 54 ± 27,
Left atrial emptying fraction, % 56 ± 9 52 ± 9 36 ± 14,
LV end-diastolic diameter, cm 4.35 ± 0.42 4.37 ± 0.46 4.30 ± 0.48
LV end-systolic diameter, cm 2.52 ± 0.38 2.69 ± 0.35 2.80 ± 0.49
LV fractional shortening, % 42.2 ± 6.9 38.5 ± 5.5 34.9 ± 7.1,§
LV thickness (septum), cm 1.00 ± 0.15 1.63 ± 0.30 1.92 ± 0.39,
LV thickness (posterior), cm 0.92 ± 0.16 1.38 ± 0.24 1.66 ± 0.32,
LV end-diastolic volume, mL 50 ± 15 54 ± 11 56 ± 16
LV end-systolic volume, mL 19 ± 6 21 ± 5 25 ± 9
LV ejection fraction, % 62 ± 5 61 ± 5 55 ± 10,§
Plasma BNP, pg/mL 30.3 ± 25.0 48.0 ± 24.6 315.5 ± 282.4,

P < 0.0001 vs. group 1.

P < 0.0001 vs. group 2.

P < 0.001 vs. group 1.

§

P < 0.01 vs. group 2.

P < 0.01 vs. group 1.

#

P < 0.05 vs. group 1.

⁎⁎

P < 0.05 vs. group 2.